Docebo Inc. (DCBO) Key Metrics
DCBO valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $688.3M
- Enterprise value
- $609.9M
- P/E (TTM)
- 24.0 10-yr median 106.3
- Forward P/E
- 10.9
- PEG ratio
- —
- Price / sales
- 2.7 10-yr median 8.5
- Price / book
- 7.3 10-yr median 10.5
- EV / EBITDA
- 24.9 10-yr median 67.3
- Dividend yield
- —
- Beta
- 0.79
DCBO key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsDCBO valuation Price multiples at each fiscal year-end price.
DCBO returns How much profit the business earns on the capital it uses.
DCBO per-share figures Results divided by the shares outstanding at year-end.
DCBO financial health Debt, liquidity and how easily interest is covered.
DCBO efficiency & capital use Working capital cycle and where the cash goes.
DCBO valuation history
DCBO returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
DCBO debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
DCBO cash returned to shareholders
DCBO price vs earnings per share
DCBO key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $652.1M | $1.39B | $1.63B | $1.13B | $2.21B | $1.88B | — | — | — | — |
| Enterprise value | $582.7M | $1.29B | $1.56B | $914.7M | $2.00B | $1.67B | — | — | — | — |
| P/E ratio | 17.4 | 51.8 | 573.7 | 160.8 | — | — | — | — | — | — |
| Price / sales | 2.7 | 6.4 | 9.0 | 7.9 | 21.2 | 29.9 | — | — | — | — |
| Price / book | 8.8 | 24.0 | 32.1 | 5.9 | 11.6 | 9.4 | — | — | — | — |
| Price / free cash flow | 22.4 | 49.5 | 106.3 | 934.7 | — | 507.6 | — | — | — | — |
| Price / operating cash flow | 21.7 | 47.4 | 102.1 | 493.1 | — | 393.1 | — | — | — | — |
| EV / sales | 2.4 | 6.0 | 8.6 | 6.4 | 19.2 | 26.5 | — | — | — | — |
| EV / EBITDA | 21.0 | 47.4 | 188.3 | 87.2 | — | — | — | — | — | — |
| EV / free cash flow | 20.0 | 46.2 | 101.7 | 757.9 | — | 449.5 | — | — | — | — |
| Earnings yield | 5.8% | 1.9% | 0.2% | 0.6% | −0.6% | −0.4% | — | — | — | — |
| Free cash flow yield | 4.5% | 2.0% | 0.9% | 0.1% | −0.2% | 0.2% | — | — | — | — |
| Dividend yield | — | — | 0.1% | — | — | 0.0% | — | — | — | — |
| Shareholder yield (dividends + buybacks) | 7.3% | 0.8% | 9.9% | 0.0% | — | 0.0% | — | — | — | — |
| Share price at fiscal year-end | $22.20 | $44.77 | $48.38 | $33.14 | $67.36 | $65.09 | — | — | — | — |
| Per share | ||||||||||
| Revenue per share | $8.26 | $7.01 | $5.37 | $4.20 | $3.17 | $2.17 | $1.70 | $0.90 | $0.57 | $0.33 |
| Earnings per share | $1.28 | $0.86 | $0.08 | $0.21 | −$0.41 | −$0.28 | −$0.49 | −$0.37 | −$0.24 | −$0.09 |
| Operating cash flow per share | $1.02 | $0.95 | $0.47 | $0.07 | −$0.10 | $0.17 | −$0.19 | −$0.10 | −$0.10 | −$0.03 |
| Free cash flow per share | $0.99 | $0.91 | $0.46 | $0.04 | −$0.13 | $0.13 | −$0.20 | −$0.11 | −$0.12 | −$0.04 |
| Cash per share | $2.52 | $2.99 | $2.14 | $6.36 | $6.55 | $7.59 | $1.90 | $0.12 | $0.11 | — |
| Book value per share | $2.52 | $1.87 | $1.51 | $5.65 | $5.80 | $6.92 | $1.29 | −$0.56 | −$0.17 | — |
| Tangible book value per share | $1.99 | $1.36 | $1.01 | $5.44 | $5.59 | $6.66 | $1.29 | −$0.56 | −$0.17 | — |
| Dividends per share | — | — | $0.07 | — | — | $0.00 | $0.00 | — | — | — |
| Capex per share | $0.03 | $0.04 | $0.02 | $0.03 | $0.03 | $0.04 | $0.02 | $0.01 | $0.02 | $0.01 |
| Debt per share | $0.15 | $0.05 | $0.06 | $0.09 | $0.12 | $0.13 | $0.14 | $0.31 | $0.11 | — |
| Shares outstanding | 29.4M | 30.9M | 33.7M | 34.0M | 32.9M | 28.9M | 24.4M | 30.1M | 30.1M | 30.1M |
| Change in shares outstanding | −5.1% | −8.1% | −1.1% | +3.6% | +13.6% | +18.8% | −19.0% | 0.0% | 0.0% | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | 57.0% | 49.3% | 2.3% | 3.7% | −7.0% | −6.9% | −163.1% | — | — | — |
| Return on assets (ROA) | 18.9% | 15.3% | 1.3% | 2.5% | −5.2% | −5.0% | −30.9% | −98.9% | −77.0% | — |
| Return on tangible assets | 19.7% | 15.3% | 2.0% | 2.5% | −5.2% | −3.2% | −18.7% | −84.7% | −77.0% | — |
| Free cash flow margin | 12.0% | 12.9% | 8.5% | 0.8% | −4.2% | 5.9% | −11.9% | −12.4% | −21.4% | −13.1% |
| Income quality (OCF / net income) | 0.80 | 1.09 | 5.62 | 0.33 | — | — | — | — | — | — |
| Financial health | ||||||||||
| Total debt | $4.5M | $1.5M | $2.1M | $3.1M | $4.0M | $3.8M | $3.5M | $9.4M | $3.3M | — |
| Cash & short-term investments | $73.9M | $92.6M | $72.0M | $216.5M | $215.4M | $219.7M | $46.3M | $3.8M | $3.4M | — |
| Net debt | −$69.4M | −$91.1M | −$69.9M | −$213.4M | −$211.4M | −$215.8M | −$42.8M | $5.6M | −$17,917 | — |
| Debt / equity | 0.06 | 0.03 | 0.04 | 0.02 | 0.02 | 0.02 | 0.11 | — | — | — |
| Debt / assets | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 | 0.71 | 0.35 | — |
| Net debt / EBITDA | −2.50 | −3.34 | −8.44 | −20.34 | — | — | — | — | — | — |
| Current ratio | 1.15 | 1.20 | 1.26 | 3.12 | 3.63 | 5.21 | 2.07 | 0.47 | 0.73 | — |
| Quick ratio | 1.15 | 1.20 | 1.20 | 3.09 | 3.63 | 5.18 | 2.04 | 0.47 | 0.73 | — |
| Interest coverage | 167.7 | 84.9 | -12.5 | 15.0 | -31.6 | -16.2 | -12.0 | -15.8 | -39.8 | — |
| Working capital | $18.0M | $25.6M | $26.5M | $179.2M | $182.3M | $192.7M | $30.4M | −$13.3M | −$3.1M | — |
| Invested capital | $4.5M | −$33.3M | −$19.2M | −$21.2M | −$20.8M | −$15.5M | −$11.4M | −$11.2M | −$5.1M | — |
| Tangible asset value | $58.4M | $42.2M | $34.1M | $185.1M | $183.8M | $192.6M | $31.4M | −$16.8M | −$6.2M | — |
| Net current asset value | $9.3M | $21.3M | $19.5M | $172.1M | $174.0M | $183.7M | $26.5M | −$18.4M | −$7.3M | — |
| Graham number | $8.51 | $6.02 | $1.69 | $5.12 | — | — | — | — | — | — |
| Graham net-net per share | −$0.56 | −$0.20 | −$0.01 | $4.55 | $4.83 | $6.13 | $0.89 | −$0.72 | −$0.30 | — |
| Capital allocation | ||||||||||
| Dividends paid | — | — | $2.2M | — | — | $0 | $0 | — | — | — |
| Share buybacks (net) | $47.9M | $11.0M | $159.4M | $0 | — | — | — | — | — | — |
| Dividend payout ratio | — | — | 77.7% | — | — | — | — | — | — | — |
| Dividends + buybacks / free cash flow | 164.5% | 39.4% | — | 0.0% | — | 0.0% | — | — | — | — |
| Capex / revenue | 0.4% | 0.6% | 0.4% | 0.8% | 1.1% | 1.7% | 0.9% | 1.5% | 4.0% | 2.6% |
| Capex / operating cash flow | 3.3% | 4.3% | 4.0% | 47.2% | — | 22.6% | — | — | — | — |
| Capex / depreciation | 0.31 | 0.37 | 0.20 | 0.46 | 0.57 | 0.89 | 0.53 | 2.43 | 3.74 | 4.13 |
| Stock-based compensation / revenue | 2.5% | 3.4% | 3.3% | 3.3% | 2.2% | 2.6% | 1.6% | 0.9% | 0.9% | 1.6% |
| R&D / revenue | 20.7% | 20.2% | 19.6% | 17.3% | 19.5% | 21.3% | 22.8% | 24.4% | 22.8% | 20.4% |
| SG&A / revenue | 48.2% | 50.4% | 59.2% | 24.4% | 71.0% | 67.8% | 76.8% | 83.4% | 88.1% | 81.7% |
| Efficiency | ||||||||||
| Days sales outstanding | 76.4 | 74.3 | 81.4 | 84.0 | 76.3 | 75.4 | 71.9 | 71.1 | 93.9 | — |
| Days of inventory on hand | — | — | 48.7 | 18.0 | 11.8 | 30.8 | 13.2 | 0.0 | — | — |
| Days payables outstanding | 269.9 | 294.0 | 305.2 | 316.6 | 342.2 | 406.6 | 357.2 | 342.7 | 320.9 | — |
| Cash conversion cycle (days) | -193.5 | -219.7 | -175.0 | -214.6 | -254.1 | -300.4 | -272.1 | -271.7 | -227.0 | — |
| Receivables turnover | 4.78 | 4.91 | 4.48 | 4.35 | 4.78 | 4.84 | 5.07 | 5.13 | 3.89 | — |
| Payables turnover | 1.35 | 1.24 | 1.20 | 1.15 | 1.07 | 0.90 | 1.02 | 1.06 | 1.14 | — |
| Inventory turnover | — | — | 7.50 | 20.27 | 30.91 | 11.83 | 27.65 | 5,650,394.00 | — | — |
| Asset turnover | 1.22 | 1.24 | 0.82 | 0.52 | 0.40 | 0.39 | 1.07 | 2.37 | 1.80 | — |
| Average receivables | $50.8M | $44.2M | $40.4M | $32.9M | $21.8M | $13.0M | $8.2M | $5.3M | $4.4M | — |
| Average payables | $35.4M | $33.3M | $28.8M | $24.4M | $19.5M | $12.9M | $8.2M | $5.3M | $3.8M | — |
| Average inventory | — | — | $4.6M | $1.4M | $672,500 | $975,000 | $302,500 | $1 | — | — |
| Intangibles / total assets | 7.5% | 8.1% | 10.5% | 2.5% | 2.6% | 3.0% | 0.0% | 0.0% | 0.0% | — |
Computed from DCBO's annual financial statements (latest annual report filed February 27, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
DCBO valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), Docebo traded at 17.4 times earnings, against a 10-year median of 106.3. Based on the latest twelve months, the trailing P/E is 24.0 and the forward P/E is 10.9. Docebo earned a return on equity of 57.0% in fiscal 2025. It ended the year with $4.5 million of debt and $73.9 million in cash and short-term investments, a net cash position of $69.4 million. It returned $47.9 million to shareholders: $0 in dividends and $47.9 million in share buybacks, 165% of free cash flow.
See the DCBO income statement, the DCBO chart for price history, or the DCBO stock overview for the latest quote and news.
DCBO key metrics FAQ
What is Docebo's P/E ratio?
Docebo's trailing P/E ratio is 24.0 based on the last twelve months of earnings (as of October 18, 2026), and its forward P/E is 10.9. At the end of fiscal 2025 it was 17.4, compared with a 10-year median of 106.3.
What is Docebo's EV/EBITDA?
Docebo's enterprise value was 21.0 times EBITDA at the end of fiscal 2025 (enterprise value $582.7 million, EBITDA $27.8 million); the current EV/EBITDA is 24.9.
What is Docebo's return on equity?
Docebo's return on equity (ROE) was 57.0% in fiscal 2025: net income of $37.5 million on average shareholders' equity of $65.9 million.
How much debt does Docebo have?
Docebo had total debt of $4.5 million at the end of fiscal 2025, a debt-to-equity ratio of 0.06 and more cash than debt.
Does Docebo buy back its shares?
Yes. Docebo spent $47.9 million on net share repurchases in fiscal 2025 Shares outstanding changed −5.1% over the year, to 29.4M..
What is Docebo's free cash flow yield?
Docebo generated $29.1 million of free cash flow in fiscal 2025, a free cash flow yield of 4.5% on its market value at year-end ($652.1 million).
What is Docebo's current ratio?
Docebo's current ratio was 1.15 at the end of fiscal 2025: current assets were 1.15 times current liabilities.